Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: Prevalence of chronic kidney disease (CKD) in people with diagnosed diabetes is known to be high, but little is known about the prevalence of CKD in those with undiagnosed diabetes or prediabetes. We aimed to estimate and compare the community prevalence of CKD among people with diagnosed diabetes, undiagnosed diabetes, prediabetes, or no diabetes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The 1999 through 2006 National Health and Nutrition Examination Survey is a representative survey of the civilian, noninstitutionalized US population. Participants who were aged > or =20 years; responded to the diabetes questionnaire; and had fasting plasma glucose (FPG), serum creatinine, and urinary albumin-creatinine ratio measurements were included (N = 8188). Diabetes status was defined as follows: Diagnosed diabetes, self-reported provider diagnosis (n = 826); undiagnosed diabetes, FPG > or =126 mg/dl without self-reported diagnosis (n = 299); prediabetes, FPG > or =100 and <126 mg/dl (n = 2272); and no diabetes, FPG <100 mg/dl (n = 4791). Prevalence of CKD was defined by estimated GFR 15 to 59 ml/min per 1.73 m(2) or albumin-creatinine ratio > or =30 mg/g; adjustment was performed with multivariable logistic regression. RESULTS: Fully 39.6% of people with diagnosed and 41.7% with undiagnosed diabetes had CKD; 17.7% with prediabetes and 10.6% without diabetes had CKD. Age-, gender-, and race/ethnicity-adjusted prevalence of CKD was 32.9, 24.2, 17.1, and 11.8%, for diagnosed, undiagnosed, pre-, and no diabetes, respectively. Among those with CKD, 39.1% had undiagnosed or prediabetes. CONCLUSIONS: CKD prevalence is high among people with undiagnosed diabetes and prediabetes. These individuals might benefit from interventions aimed at preventing development and/or progression of both CKD and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, evidence of a cross-sectional association between prediabetes and eGFR, a late marker of CKD, is mixed, including both studies with positive54 and null findings.55,57”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredIn the citing paper
“The NHANES 1999–2006 showed increasing frequency of albuminuria in tandem with the glycaemia range when classified from normoglycaemia through IFG, undiagnosed diabetes and diagnosed diabetes for both microalbuminuria, which may also relate to hypertension and is therefore an imprecise marker of diabetes-related early nephropathy (6%, 10%, 29% and 29%, respectively) and macroalbuminuria (0.6%, 1.1”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [54]
In the citing paper
“There is evidence to link prediabetes to increased risk of early forms of nephropathy and chronic kidney disease (CKD), defined based on methods such as urinary albumin excretion rate (AER) and estimated glomerular filtration rate (eGFR).51–55”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Self-citationDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725 · cited 9×
“The unadjusted CKD prevalence using the MDRD Study equation (7) was 39.6 and 41.7% in those with diagnosed and undiagnosed diabetes, respectively (Figure 1A).”
MethodInfluentialSelf-citationBasevi, V., Di Mario, S., Morciano, C., Nonino, F., & Magrini, N. (2011) · Diabetes Care · doi:10.2337/dc11-0174 · Cited by 3,055
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006
Cowie, C. C., Rust, K. F., Ford, E. S., Eberhardt, M. S., Byrd-Holt, D. D., Li, C., Williams, D. E., Gregg, E. W., Bainbridge, K. E., Saydah, S. H., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1296 · Cited by 1,154
Self-citationChronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000
Coresh, J., Byrd-Holt, D., Astor, B. C., Briggs, J. P., Eggers, P. W., Lacher, D. A., & Hostetter, T. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070539 · Cited by 842
Self-citationKramer, H. J. (2003) · JAMA · doi:10.1001/jama.289.24.3273 · Cited by 618 · cited 1×
“We defined CKD as either reduced kidney function or elevated albuminuria, because reduced kidney function may occur even in the absence of albuminuria in those with type 2 diabetes (5,6).”
BackgroundImprovements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988–2002
Saaddine, J. B., Cadwell, B., Gregg, E. W., Engelgau, M. M., Vinicor, F., Imperatore, G., & Narayan, K. M. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-7-200604040-00005 · Cited by 571
Research works printed but not linked: 3
- US Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009 [Google Scholar]
- Centers for Disease Control and Prevention: National diabetes fact sheet: General information and national estimates on diabetes in the United States, 2007, Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, 2008. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf Accessed February 1, 2009 [Google Scholar]
- Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290: 2159–2167, 2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
Cited by
Items 201–300 of 421
Liu, L., Gao, B., Wang, J., Yang, C., Wu, S., Wu, Y., Chen, S., Li, Q., Zhang, H., Wang, G., et al. (2020) · Journal of Diabetes Research · doi:10.1155/2020/2720905 · Cited by 11
“Nonimmunosuppressive treatment lowering the level of hs-CRP has been shown to be beneficial to kidney outcomes and cardiovascular disease in patients with CKD [20].”
BackgroundInfluentialLiu, Q., Zheng, D., Shen, X., Jin, J., & He, Q. (2024) · International Urology and Nephrology · doi:10.1007/s11255-024-04308-x · Cited by 13
Fabbian, F., Giorgi, A. D., Monesi, M., Pala, M., Tiseo, R., Misurati, E., Parisi, C., Volpi, R., Graziani, R., Mikhailidis, D. P., et al. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114552656 · Cited by 11
“12(1) 46 –52 © The Author(s) 2014 Reprints and permissions: sagepub.”
InfluentialNalawade, M. L., Patil, R., Bavkar, L. N., Rooge, S. B., Haldavnekar, V., & Arvindekar, A. U. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.12.025 · Cited by 11
Ethnic differences in the relationship of prediabetes with the presence of target-organ disease
Player, M. S., Díaz, V. A., Mainous, A. G., Gregorie, S. H., Knoll, M. E., & Everett, C. J. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.12.009 · Cited by 11
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_8-1 · Cited by 13
Soric, M. M., Moorman, J. M., Boyle, J. A., & Crish, S. D. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1772 · Cited by 12
“6%.(29) Similarly, the weighted prevalence of congestive heart failure in patients with diabetes was only 4.”
BackgroundSugimoto, H., Hironaka, K., Nakamura, T., Yamada, T., Miura, H., Otowa‐Suematsu, N., Fujii, M., Hirota, Y., Sakaguchi, K., Ogawa, W., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00819-5 · Cited by 11
Sourij, C., Bergmair, T., Aziz, F., Kojzar, H., Knoll, L., Clodi, M., Fasching, P., Krauter, A., Schaffenrath, M., Kaser, S., et al. (2025) · Obesity Facts · doi:10.1159/000547108 · Cited by 10
Singh‐Franco, D., Harrington, C. A., & Tellez‐Corrales, E. (2016) · SAGE Open Medicine · doi:10.1177/2050312116659090 · Cited by 12
Lower-Intensity Interventions for Prediabetes: A Systematic Review
Tseng, E., Lam, K. Y., Meza, K., O’Brien, M. J., & Maruthur, N. M. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.05.012 · Cited by 12
Ghannam, N., Alahmed, S., Aldahash, R., Aljohani, N., Alshammary, A., Amir, A., Kamal, A., Khader, S., Salah, M., Shalabi, H., et al. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s396621 · Cited by 10
Do We Now Have a Prognostic Biomarker for Progressive Diabetic Nephropathy?
Brosius, F. C., & Saran, R. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010090 · Cited by 10
Self-citationTsuchida, K., Mitsuma, W., Sato, Y., Ozaki, K., Soda, S., Hatada, K., Tanaka, K., Hosaka, Y., Imai, S., Takahashi, K., et al. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01394-7 · Cited by 10
Zhou, Y., Qin, S., Zhu, Y., Xu, P., & Gu, K. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1288416 · Cited by 10
Choi, J. Y., Ali, M. K., & Choi, D. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111634 · Cited by 9
Sustained Klotho delivery reduces serum phosphate in a model of diabetic nephropathy
Hum, J. M., O’Bryan, L. M., Tatiparthi, A. K., Clinkenbeard, E. L., Ni, P., Cramer, M. S., Bhaskaran, M., Johnson, R. L., Wilson, J. M., Smith, R. C., et al. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00838.2018 · Cited by 9
“Diabetes is currently the greatest risk factor for developing chronic kidney disease (CKD), affecting 40% of patients with diabetes (60).”
BackgroundLimited Effectiveness of Diabetes Risk Assessment Tools in Seniors’ Facility Residents
Featherstone, T. R., Eurich, D. T., & Simpson, S. H. (2016) · Value in Health · doi:10.1016/j.jval.2016.09.2403 · Cited by 9
“[15] Plantinga LC, Crews DC, Coresh J, et al.”
BackgroundBin-Meferij, M. M., El-kott, A. F., Shati, A. A., & Eid, R. A. (2019) · International Journal of Morphology · doi:10.4067/s0717-95022019000200438 · Cited by 9
Pancreatic Angiopathy Associated With Islet Amyloid and Type 2 Diabetes Mellitus
Ling, W., Huang, Y., Huang, Y., Shen, J., Wang, S.-H., & Zhao, H. (2020) · Pancreas · doi:10.1097/mpa.0000000000001664 · Cited by 9
Current and emerging pharmacotherapy for prediabetes: are we moving forward?
Mangan, A., Docherty, N. G., le Roux, C. W., & Al‐Najim, W. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1517155 · Cited by 9
Al-Momany, A., Almomani, E. Y., Almomani, H. Y., Al-Azzam, S. I., & Qablan, A. M. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073536 · Cited by 8
“18 19 The difference in DKD prevalence might be due to the differences in the number of diabetes cases included in the studies, some of the studies included T2DM only, others included both T1DM and T2DM.”
ResultJairoun, A. A., Ping, C. C., & Ibrahim, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-58574-x · Cited by 10
Alkattan, A., Alzeer, A. H., Alsaawi, F., Alyahya, A., Alnasser, R. A., Alsarhan, R., Almusawi, M. A., Alabdulaali, D., Mahmoud, N., Al‐Jafar, R., et al. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2400706 · Cited by 8
“Two studies with larger numbers of participants showed that the prevalence of high-risk T2DM was 23% and 22.7%, respectively [59,60].”
InfluentialWang, S., Niu, J., Zhao, Z., Xu, M., Lu, J., Li, M., Wang, T., Chen, Y., Wang, S., Dai, M., et al. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13028 · Cited by 8
Yu, E. S., Hong, K., & Chun, B. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-76661-7 · Cited by 8
Metabolic risks in living kidney donors in South Korea
Kang, E., Park, J., Kim, H. J., Park, S., Park, M., Kim, Y., Kim, K., Park, S. M., Chae, D., Chin, H. J., et al. (2021) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.20.271 · Cited by 8
“Type 2 DM is a leading cause of CKD and ESKD worldwide [36,37].”
BackgroundSignificance of prediabetes as a nosological entity
Stepanek, L., Horakova, D., Nakladalova, M., Cibickova, L., Karasek, D., & Zadrazil, J. (2018) · Biomedical Papers · doi:10.5507/bp.2018.057 · Cited by 7
Using Risk Assessment to Improve Screening for Albuminuria among US Adults without Diabetes
Bragg‐Gresham, J. L., Annadanam, S., Gillespie, B. W., Li, Y., Powe, N. R., & Saran, R. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-09185-9 · Cited by 7
Self-citationMultiple pesticide exposure and impaired glucose regulation in U.S. non-diabetic population
Zhu, X., Chen, C., Liu, Q., Zhu, Z., Wu, X., & Zhang, Y. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.125519 · Cited by 6
Ciesielski, W., Frąk, W., Gmitrzuk, J., Kuczyński, P., Klimczak, T., Durczyński, A., Strzelczyk, J., & Hogendorf, P. (2025) · Polish Journal of Surgery · doi:10.5604/01.3001.0054.9677 · Cited by 7
Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes Care
Hurwitz, J. T., Grizzle, A. J., Augustine, J. M., Rehfeld, R. A., Wild, A., & Abraham, I. L. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.22.1.40 · Cited by 7
“The patients’ age quartile overall was a statistically significant predictor (Wald χ(2) [3] = 61.”
BackgroundMethodInfluentialChen, C.-L., & Pan, T. (2015) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2015.04.013 · Cited by 7
“[31] Plantinga LC, Crews DC, Coresh J, Miller ER, Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS, Williams DE, Powe NR.”
BackgroundRathi, N., Whelton, P. K., Chertow, G. M., Cushman, W. C., Cheung, A. K., Wei, G., Boucher, R. E., Kimmel, P. L., Bress, A. P., Kramer, H., et al. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz105 · Cited by 7
Pharmacotherapeutic options for prediabetes
Rendell, M. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1817381 · Cited by 9
Ephraim, R. K. D., Mantey, R., Atombo, S., Sakyi, S. A., Fondjo, L. A., Tashie, W., Agbodzakey, H., Botchway, F. A., & Amankwaa, B. (2018) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2018.07.003 · Cited by 7
“The Plantinga et al.16 report showed a lower mean age, and included T1DM patients and those diagnosed with T2DM age 30 years.”
BackgroundResultInfluentialJawed, I., Feroze, A., Zahid, M., Ahmad, M. M., Kaleem, S. H., Saadia, S., Salman, M., Khan, M. K., Mehmood, M., Rashid, S., et al. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003822 · Cited by 6
“Similarly, one in every three with diabetes have CKD [ 8 ] and 39.1% of CKD patients in the United States have diabetes or prediabetes [ 9 ] .”
InfluentialLundgaard, A. T., Westergaard, D., Röder, T., Burgdorf, K. S., Larsen, M. H., Schwinn, M., Thørner, L. W., Sørensen, E., Nielsen, K. R., Hjalgrim, H., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06231-3 · Cited by 6
“This is in line with previous studies showing that nephropathy and retinopathy are some of the earliest clinical indications of diabetes [37, 38].”
Prediabetes and CKD: Does a causal relationship exist
Rico-Fontalvo, J. E., Soler, M. J., Daza-Arnedo, R., Navarro‐Blackaller, G., Medina-González, R., Yánez, T. R., Cardona-Blanco, M., Cabrales, J., Uparrela-Gulfo, I., & Chavez-Iñiguez, J. S. (2024) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2024.11.005 · Cited by 8
Henderson, C. E. (2012) · The Open Diabetes Journal · doi:10.2174/1876524601205010025 · Cited by 6
“Kidney damage has also been found to antecede the diagnosis of diabetes, with approximately 42% of those determined to have diabetes in the NHANES data also having attendant chronic kidney disease [24].”
BackgroundChronic Kidney Disease and Dialysis
Little, J. W., Falace, D. A., Miller, C. S., & Rhodus, N. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-323-08028-6.00012-9 · Cited by 6
Estimating the cost of chronic kidney disease in Australia
Randall, S. M., Lee, C., Thomas, E., Chakera, A., Chai, K. E. K., Varhol, R., Mehta, K., Irish, A. B., Conradie, J., Hadlow, N. C., et al. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-11953-6 · Cited by 6
“However results from other studies, including the Aus-Diab study and data from the NHANES study in the US [22] have also shown higher diabetes rates similar to our results in early-stage CKD, when measuring a random sample of the population (i.e. without likely selection bias).”
Obayashi, K., Saeki, K., & Kurumatani, N. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07700715 · Cited by 6
Analysis of the Type 2 Diabetic Patients Followed in a University Clinic
Koçak, M. Z., Aktaş, G., Erkuş, E., Duman, T. T., Tel, B. M. A., & Şavlı, H. (2018) · Konuralp Tıp Dergisi · doi:10.18521/ktd.345149 · Cited by 6
“Vitamin D (ng/ml) 13,9(3,4-36) 9,4(4,9-34) 0.”
BackgroundFang, F., Wang, N., Yan, S., Wang, L., Lu, Y., Li, J., Li, H., Pham, G., Li, C., Leng, S. X., et al. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.01.004 · Cited by 6
George, C., Hill, J., Nqebelele, U., Peer, N., & Kengne, A. P. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068672 · Cited by 8
Gabriel, R., Boukichou-Abdelkader, N., Gilis‐Januszewska, A., Makrilakis, K., Gómez‐Huelgas, R., Kamenov, Z. A., Paulweber, B., Satman, İ., Djordjević, P., Alkandari, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12052035 · Cited by 7
Ladányi, E., Salfer, B., Balla, J., Kárpáti, I., Reusz, G., Szabó, L., Andriska, P., Németh, L., Wittmann, I., & Laczy, B. (2023) · International Journal of Public Health · doi:10.3389/ijph.2023.1606151 · Cited by 9
“Given the number of registered type 2 DM patients in this study, by calculating with about 40% prevalence rate [4, 29, 45, 46], the number of individuals with CKD in type 2DM would be projected as 230,000 in Hungary, which approximated the international estimation [7].”
BackgroundIsrael, E., Borko, U. D., Mota, K., Tesfaw, M., Feleke, T., Abraham, A., Akako, B., Samuel, B., & Aynalem, A. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1326011 · Cited by 6
Washirasaksiri, C., Pakornnipat, W., Ariyakunaphan, P., Kositamongkol, C., Polmanee, C., Preechasuk, L., Jaiborisuttigull, N., Sitasuwan, T., Tinmanee, R., Pramyothin, P., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-58739-8 · Cited by 6
“The US Centers for Disease Control and Prevention 10 expanded the scope of the US DPP through the National DPP, a 12-month program incorporating the successful elements of the trial.”
MethodJadhakhan, F., Marshall, T. P., & Gill, P. S. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0059-6 · Cited by 8
“6 % in those without glycaemic abnormality [13].”
Managing Chronic Kidney Disease in Type 2 Diabetes in Family Practice
Scott, D., & Davidson, J. A. (2011) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30452-1 · Cited by 7
Chronic Kidney Disease and Diabetes–A Potential Causal Link
Lai, S. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.03.025 · Cited by 6
“…nearly 40% of people with diagnosed and 41.7% with undiagnosed diabetes had CKD; 17.7% with prediabetes and 10.6% without diabetes had CKD (Plantinga et al., 2010), while in a primary care setting in Finland, approximately 70% of patients with T2D have some sign of CKD and about half of…”
BackgroundInfluentialCornelius, B. W. (2016) · Anesthesia Progress · doi:10.2344/0003-3006-63.4.208 · Cited by 6
“Chronic kidney disease, also a form of microvascular disease, affects up to 40% of diabetic patients.(22) Because of the way chronic kidney disease affects insulin pharmacokinetics, insulin-dependent diabetic patients with this comorbidity have a higher risk of developing hypoglycemia.”
BackgroundCross-sectional study of diabetes kidney disease in the Eastern Cape, South Africa
Adeniyi, O. V., & Owolabi, E. O. (2020) · Medicine · doi:10.1097/md.0000000000023303 · Cited by 8
Liu, J., Ssewamala, F. M., An, R., & Ji, M. (2025) · JMIR AI · doi:10.2196/68260 · Cited by 5
“National surveillance shows that nearly half of those with undiagnosed diabetes have hypertension, lipid abnormalities, or cardiovascular and chronic kidney diseases [45-48].”
Yin, J., Luo, M., Fu, Q., & Zhu, H. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02081-1 · Cited by 5
“Multiple epidemiological survey results have shown that approximately 30% to 40% of diabetic patients and 16% to 18% of prediabetic patients have CKD [4, 5].”
Spennati, G., Vo, N., Regier, M. C., Ward, H. H., Das, V., Karihaloo, A., & Freedman, B. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.103081 · Cited by 5
Sneed, N. M., Azuero, A., Moss, J. A., Goss, A. M., & Morrison, S. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0286759 · Cited by 5
“, hypertension, dyslipidemia),(4) independent 127 of T2D progression.(3,4) Significant disparities in the prevalence of prediabetes are observed 128”
BackgroundPrediabetes and CKD: Does a causal relationship exist
Rico-Fontalvo, J. E., Soler, M. J., Daza-Arnedo, R., Navarro‐Blackaller, G., Medina-González, R., Yánez, T. R., Cardona-Blanco, M., Cabrales, J., Uparrela-Gulfo, I., & Chavez-Iñiguez, J. S. (2024) · Nefrología · doi:10.1016/j.nefro.2024.06.008 · Cited by 8
“43 Very similar to the descriptive cross-sectional study that evaluated 91 patients with CKD not associated with DM, the authors found that 41% of the study subjects met the criteria for preDM; amongst them, 18.7% had impaired FPG, 7.7% had impaired glucose tolerance, and 15.4% presented both.”
InfluentialInfluence of metabolic disorders on the development of renal pathology
Bashkinov, R. A., Батлук, Т. И., Мельников, Е. С., Trubnikova, M. A., & Arutyunov, A. G. (2022) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2022-3-2-7-18 · Cited by 5
Selective somatostatin receptor 5 inhibition improves hepatic insulin sensitivity
Tamura, Y. O., Sugama, J., Abe, S., Shimizu, Y., Hirose, H., & Watanabe, M. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1043 · Cited by 5
Shih, H.-M., Tsai, W., Wu, P., Chiu, L.-T., & Kung, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-43513-z · Cited by 5
“These results indicate that the prevalence of chronic kidney disease in patients with undiagnosed diabetes is higher than that in patients with prediabetes and that in diagnosed patients 30 .”
BackgroundFabbian, F., Giorgi, A. D., Monesi, M., Pala, M., Tiseo, R., Forcellini, S., Storari, A., Graziani, R., Volpi, R., Mikhailidis, D. P., et al. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.05.003 · Cited by 5
“Renal dysfunction has been reported to be related with diagnosed, undiagnosed and pre-DM, besides more than one third of subjects with CKD have been reported to have DM [Plantinga et al., 2010].”
BackgroundAssessment of Serum Creatinine and Kidney Function among Incident Metformin Users
Schorr, M., Hemmelgarn, B. R., Tonelli, M. A., Soo, A., Manns, B., & Bresee, L. C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.05.002 · Cited by 5
Mulu, G. B., Kebede, W. M., Tarekegn, F. N., Engida, A. S., Endawoke, M., Menalu, M. M., Mossie, Y., Wubshet, T., & Atinafu, B. T. (2023) · Journal of Clinical Nephrology · doi:10.29328/journal.jcn.1001104 · Cited by 5
“The Prevalence of diabetic nephropathy is measured to be 23.8% in Zambia, 14% - 16% in South Africa, 12.4% in Egypt, 9% in Sudan and 6.1% in Ethiopia [15].”
BackgroundInfluentialOhara, C., Inoue, K., Kashima, S., Inoue, M., & Akimoto, K. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.06.007 · Cited by 8
“The prevalence of chronic kidney disease in undiagnosed diabetes patients was higher than these with clinical diabetes [11].”
BackgroundLiu, H., Zhou, C., Yu, J., Jiang, Q., & Hu, D. (2013) · Nephrology · doi:10.1111/nep.12033 · Cited by 5
“Plantinga and colleagues reported that CKD prevalence is high in US adults with undiagnosed diabetes and pre-diabetes.(4) The potential clinical and public policy implications behind this deserve consideration.”
BackgroundAddressing the ESRD Risks of the Young Living Kidney Donor: Putting “Normal for Now” into Practice
Steiner, R. W. (2016) · Current Transplantation Reports · doi:10.1007/s40472-016-0083-z · Cited by 6
Cardiovascular-Kidney-Metabolic Health
Solomon, M., Claudel, S. E., & Verma, A. (2025) · Cardiology Clinics · doi:10.1016/j.ccl.2025.03.001 · Cited by 4
Kim, C. S., Suh, S. H., Choi, H. S., Bae, E. H., Kwon, S., Kim, B., Han, K.-D., & Kim, S. W. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i5.102094 · Cited by 6
Ikeme, J. C., Scherzer, R., Garimella, P. S., Hallan, S. I., Katz, R., Estrella, M. M., Ix, J. H., & Shlipak, M. G. (2025) · Kidney Medicine · doi:10.1016/j.xkme.2025.101118 · Cited by 4
“5 Uromodulin (UMOD) is a protein produced exclusively in the thick ascending limb of the loop of Henle and found at high concentrations in the urine.”
Liu, T., & Li, M. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1599097 · Cited by 4
“Between 25% and 50% of diabetic patients may develop CKD, commonly referred to as DN (Li et al., 2016; Plantinga et al., 2010).”
Mas, S., Civantos, E., Boukichou-Abdelkader, N., Moreno, J. A., Tuomilehto, J. O., Gabriel, R., & Egido, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-79842-w · Cited by 5
Fiorentino, T. V., Vito, F. D., Natale, R. M., Sergi, S., Rubino, M., Cassano, V., Succurro, E., Sciacqua, A., Andreozzi, F., & Sesti, G. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112075 · Cited by 4
Prediabetes: A Benign Intermediate Stage or a Risk Factor in Itself?
Mulla, I. G., Anjankar, A. P., Pratinidhi, S. A., Agrawal, S. V., Gundpatil, D., & Lambe, S. D. (2024) · Cureus · doi:10.7759/cureus.63186 · Cited by 6
Zenteno-Castillo, P., Muñoz-López, D. B., Merino-Reyes, B., Vega-Sánchez, Á. E., Preciado‐Puga, M. D. C., González-Yebra, A. L., & Kornhauser, C. (2015) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2015.08.001 · Cited by 5
Managing Diabetes in Patients With Diabetes of Long Duration
Triplitt, C. (2012) · The diabetes educator · doi:10.1177/0145721712449390 · Cited by 4
“Almost 40% of patients with diagnosed diabetes exhibit some evidence of CKD.(14)”
BackgroundHarris, S. B., Aschner, P. J., Mequanint, S., & Esler, J. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.05.010 · Cited by 4
Tanabe, H., Saito, H., Machii, N., Kudo, A., Tanaka, K., Asahi, K., Kazama, J. J., & Shimabukuro, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072028 · Cited by 4
“The risk factor for each condition was in the sequence: No diabetes < pre-diabetes < DD < UD [25].”
BackgroundHigher-Dose Sitagliptin and the Risk of Congestive Heart Failure in Older Adults with CKD
Muanda, F. T., Weir, M. A., Bathini, L., Clemens, K. K., Perkovic, V., Sood, M. M., McArthur, E., Sontrop, J. M., Kim, R. B., & Garg, A. X. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08310520 · Cited by 4
Soluble LRIG2 is a potential biomarker for type 2 diabetes mellitus
Kim, J. M., Joung, K. H., Lee, J. C., Choung, S., Kang, S. M., Kim, H. J., & Ku, B. J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-3272 · Cited by 4
The prevalence and risk factors of retinopathy and nephropathy in prediabetic population
Güney, S. C., Cay, Y., Şimşir, İ. Y., Kabaroğlu, C., Afrashı, F., & Saygılı, F. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01105-z · Cited by 4
“6% in the normal glucose tolerance (NGT) group [21].”
BackgroundGidey, G., Hiruy, M., Teklu, D., Ramanathan, K., & Gebreyesus, H. A. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s307823 · Cited by 4
“Prediabetes produces no symptoms but it is a substantial risk factor for developing type 2 diabetes mellitus (T2DM) and its consequences.(4,5) It has been estimated that a prediabetic person is 5 to 15 times more likely to develop T2DM compared to a normoglycemic one.”
BackgroundDinar, Y., Elkhoudri, N., & Belahsen, R. (2015) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-150040 · Cited by 4
“%) are affected, 522600 people died of diabetes associated disorder and 63% have undiagnosed diabetes and already have complications [6–8]. that they are affected.”
Diabetes mellitus doubles the risk of type 2 cardiorenal syndrome: results from the NHANES trial
Tentolouris, N., & Eleftheriadou, I. (2017) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2017.11.013 · Cited by 4
Aldafas, R., Vinogradova, Y., Crabtree, T. S. J., Gordon, J. P., & Idris, I. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109292 · Cited by 3
The evolving continuum of dysglycaemia: Non‐diabetic hyperglycaemia in older adults
Golding, J. A., Hope, S. V., Chakera, A. J., & Puttanna, A. (2023) · Diabetic Medicine · doi:10.1111/dme.15177 · Cited by 3
Alicic, R. Z., Duru, O. K., Jones, C. R., Kornowske, L. M., Daratha, K. B., Reynolds, C., Pavkov, M. E., Koyama, A. K., Xu, F. Z., Nicholas, S. B., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16365 · Cited by 3
Self-citationZhang, J., Xu, H., Liu, Y., Lyu, Y., Bian, W., Song, Z., Liu, Y., Ma, G., Liu, Y., Chen, T., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112323 · Cited by 4
Health implications of prediabetes and the role of trace elements in insulin resistance
Amer, H. M., Aboelyazed, S., Elshafeey, F., & Elhalawany, S. H. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00811-9 · Cited by 3
“Cross-sectional studies have produced mixed results, with some showing positive associations [81], while others have found no significant link [83] .”
Diagnosis of Prediabetes and Diabetes Prevention
Buysschaert, M., & Bergman, M. (2013) · Wiley eBooks · doi:10.1002/9781118661321.ch3 · Cited by 4
Chang, S., Yeh, H.-C., & Kuo, Y.-L. (2020) · Journal of Korean Academy of Nursing · doi:10.4040/jkan.2020.50.2.298 · Cited by 3
Li, L., Wang, F., Xu, M., Lu, J. L., Zhao, Z. Y., Li, M., Wang, T. G., Wang, S. Y., Bi, Y. F., Xu, Y., et al. (2021) · PubMed · doi:10.3967/bes2021.106 · Cited by 3
Katsiki, N., Geiss, E., Giesen, A., Jehn, A., Rammos, C., Karcher, J. C., Schöfthaler, C., & Korosoglou, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216385 · Cited by 2
Integrating GWAS and machine learning for disease risk prediction in the Taiwanese Hakka population
Xiao, J., Kang, H.-Y., Wu, L.-C., Hsu, T., Wu, C., & Su, L. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1694084 · Cited by 2
“…a range of severe complications, including cardiovascular disease, kidney disease, eye disorders, neurological damage, lower-limb amputations, pregnancy-related complications, and premature mortality (Flores-Le Roux et al., 2011; Plantinga et al., 2010; Spijkerman et al., 2003; Organization, 2009).”
Lapsiwala, B. J., Nathani, P. S., Bhalodia, A. R., Rangan, A., Rajpopat, P. B., Khan, F., Vaghani, U., Kanagala, S. G., Chandramohan, D., Naik, R., et al. (2026) · Postgraduate Medical Journal · doi:10.1093/postmj/qgag009 · Cited by 2
Alogliptin for the treatment of Type 2 diabetes
Seino, Y., & Yabe, D. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.968553 · Cited by 2
“A substantial number of patients with Type 2 diabetes will have some degree of renal impairment [61].”
BackgroundSoejima, H., Ogawa, H., Morimoto, T., Okada, S., Matsumoto, C., Nakayama, M., Masuda, I., Jinnouchi, H., Waki, M., Saito, Y., et al. (2022) · Heart and Vessels · doi:10.1007/s00380-022-02085-0 · Cited by 2
Lin, H., Wang, J., Tseng, P.-Y., Fu, L., Lee, Y., Wu, M., Yang, W., & Chiu, H. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110567 · Cited by 2
Metadata
- Authors
- Plantinga, L. C., Crews, D. C., Coresh, J., Miller, E. R., Saran, R., Yee, J., Hedgeman, E., Pavkov, M., Eberhardt, M. S., Williams, D. E., & Powe, N. R.
- Affiliations
- San Francisco General Hospital (US)
- Johns Hopkins University (US)
- University of Michigan (US)
- Henry Ford Health (US)
- Centers for Disease Control and Prevention (US)
- University of California, San Francisco (US)
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2010-04
- Volume
- 5
- Issue
- 4
- Pages
- 673-682
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC2849697
- OpenAlex
- W2128714303
- Cited by
- 408
- References
- 28
- Citations by year
- 2026: 12 · 2025: 28 · 2024: 24 · 2023: 25 · 2022: 18 · 2021: 30 · 2020: 28 · 2019: 29 · 2018: 32 · 2017: 26 · 2016: 34 · 2015: 31 · 2014: 27 · 2013: 28 · 2012: 15
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K24 DK02643, K24DK002643)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- chronic kidney disease, undiagnosed diabetes, prediabetes, diabetes prevalence, albumin-creatinine ratio, estimated glomerular filtration rate, NHANES, diabetes screening
- MeSH terms
- Adult, Albuminuria, Blood Glucose, Chronic Disease, Creatinine, Diabetes Mellitus, Fasting, Female, Glomerular Filtration Rate, Health Surveys, Humans, Kidney Diseases, Male, Mass Screening, Middle Aged, Prediabetic State, Predictive Value of Tests, Surveys and Questionnaires, United States, Biomarkers, Comorbidity, Prevalence, Chi-Square Distribution, Logistic Models, Early Diagnosis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.